Cholecystokinin (CCK) Neurons

Cholecystokinin (CCK) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cholecystokinin (CCK) Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Cholecystokinin (CCK) Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Introduction

Cholecystokinin (Cck) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cholecystokinin (CCK) neurons are peptide-expressing neuronal populations found in cortex, hippocampus, amygdala, hypothalamus, and multiple subcortical networks. In the CNS, CCK is both a neuropeptide transmitter and a circuit-level modulator that interacts with GABAergic interneurons, endocannabinoid tone, and state-dependent excitability.[@beinfeld2020][@freund2007]

Overview

Cholecystokinin (CCK) neurons represent a diverse population of GABAergic interneurons characterized by their expression of the cholecystokinin peptide. These neurons play crucial roles in modulating anxiety, memory, pain perception, and appetite regulation. In the context of neurodegenerative diseases, CCK neurons are increasingly recognized for their involvement in circuit dysfunction and their potential as therapeutic targets.

...

Cholecystokinin (CCK) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cholecystokinin (CCK) Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Cholecystokinin (CCK) Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>

Introduction

Cholecystokinin (Cck) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cholecystokinin (CCK) neurons are peptide-expressing neuronal populations found in cortex, hippocampus, amygdala, hypothalamus, and multiple subcortical networks. In the CNS, CCK is both a neuropeptide transmitter and a circuit-level modulator that interacts with GABAergic interneurons, endocannabinoid tone, and state-dependent excitability.[@beinfeld2020][@freund2007]

Overview

Cholecystokinin (CCK) neurons represent a diverse population of GABAergic interneurons characterized by their expression of the cholecystokinin peptide. These neurons play crucial roles in modulating anxiety, memory, pain perception, and appetite regulation. In the context of neurodegenerative diseases, CCK neurons are increasingly recognized for their involvement in circuit dysfunction and their potential as therapeutic targets.

Key Characteristics:

• Neuropeptide: Cholecystokinin (CCK)
• Neurotransmitter: GABA (primary)
• Receptors: CCK1R, CCK2R, CB1 (cannabinoid)
• Brain Regions: Cortex, hippocampus, amygdala, hypothalamus

Cellular Identity And Subtypes

CCK-expressing neurons are not a single electrophysiologic class. Important subgroups include:

• CCK-positive basket-like interneurons (especially in cortex and hippocampus)
• Long-range or local CCK peptide neurons outside canonical interneuron compartments
• Mixed-identity neurons co-expressing markers such as GAD1/GAD2 and, in subsets, CNR1 (CB1 receptor)[@freund2007][@katona1999]

This diversity matters for disease interpretation: transcript-level CCK shifts can reflect inhibitory circuit remodeling, peptide-state transitions, or both.[@freund2007][@verret2012]

Circuit Physiology

Perisomatic Inhibitory Control

In cortical-hippocampal microcircuits, CCK interneuron subclasses contribute to perisomatic inhibition of principal neurons. Compared with fast-spiking PV systems, CCK-associated inhibition is often more neuromodulator-sensitive and context-gated.[@freund2007][@katona1999]

Endocannabinoid Sensitivity

A central feature of many CCK interneurons is high CB1 receptor expression. Retrograde endocannabinoid signaling can transiently suppress GABA release from these terminals, dynamically changing local excitation-inhibition balance during behavior and plasticity.[@katona1999][@wilson2001]

Network State Modulation

CCK pathways influence anxiety-related processing, sensory salience gating, and mnemonic encoding/retrieval states. These effects likely emerge from combined peptide signaling plus rapid GABAergic synaptic actions.[@beinfeld2020][@freund2007]

Relevance To Neurodegenerative Disorders

Alzheimer's Disease

In Alzheimer's disease, inhibitory microcircuit disruption is a recurrent systems finding. CCK-positive inhibitory populations are part of this vulnerability landscape and may contribute to network hyperexcitability, oscillatory desynchronization, and cognitive instability when inhibitory reserve declines.[@verret2012][@palop2010]

Parkinson's Disease And Non-Motor Symptoms

In Parkinson's disease, CCK signaling has been linked more strongly to non-motor circuit domains (mood, anxiety, sleep, and cognitive flexibility) than to direct nigrostriatal neurodegeneration. This suggests a modulatory role in symptom expression rather than a primary etiologic role.[@beinfeld2020][@tovote2015]

Epileptiform Susceptibility And Excitability Stress

Because CCK systems participate in inhibitory regulation and neuromodulator-sensitive gating, they are relevant to seizure susceptibility and excitability stress states that can coexist with neurodegenerative pathology.[@trevelyan2013][@ascoli2008]

Translational Implications

Potential intervention axes include:

• CCK receptor subtype-selective ligands for anxiety/cognitive symptom clusters
• Targeted modulation of CCK-CB1 microcircuits to normalize inhibitory dynamics
• Combined peptide-circuit approaches alongside disease-modifying therapies

The strongest current translational case is for circuit-symptom modulation (especially anxiety/arousal domains), while definitive disease-modifying evidence in AD/PD remains limited.[@beinfeld2020][@freund2007]

• Cholecystokinin Interneurons
• Cholecystokinin-Expressing Interneurons (CCK Interneurons)
• Vasoactive Intestinal Peptide Interneurons
• Fast-Spiking Parvalbumin Interneurons
• [Neuroinflammation](/mechanisms/neuroinflammation)

External Links

• [PubMed: cholecystokinin neurons](https://pubmed.ncbi.nlm.nih.gov/?term=cholecystokinin+neurons+brain)
• [Allen Brain Atlas](https://portal.brain-map.org/)

Background

The study of Cholecystokinin (Cck) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — associated_with
• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — expressed_in
• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — inhibits
• [ADAM10 — A Disintegrin And Metalloproteinase Domain 10](/wiki/genes-adam10) — inhibits

Pathway Diagram

The following diagram shows the key molecular relationships involving Cholecystokinin (CCK) Neurons discovered through SciDEX knowledge graph analysis: